Clinical Trial Update: A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy [Phase 3]

View source ↗

Summary

This Clinical Trial Update describes a Phase 3 study evaluating epoetin alfa to maintain hemoglobin levels in patients with metastatic breast cancer undergoing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Breast Cancer

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia, Breast Neoplasms | Phase 3 | Status: COMPLETED